Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-02-04T00:48:32.578Z Has data issue: false hasContentIssue false
  • English
  • Français

A Double-Blind Placebo-Controlled Study of Buspirone in Diazepam Withdrawal in Chronic Benzodiazepine Users

Published online by Cambridge University Press:  02 January 2018

C. H. Ashton ,
M. D. Rawlins  and
S. P. Tyrer
C. H. Ashton*
Affiliation:
Clinical Psychopharmacology Unit, Department of Pharmacological Sciences, University of Newcastle upon Tyne, NE2 4HH
M. D. Rawlins
Affiliation:
University of Newcastle upon Tyne
S. P. Tyrer
Affiliation:
Royal Victoria Infirmary, Newcastle upon Tyne
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Extract

A double-blind placebo-controlled trial of 23 chronic benzodiazepine users showed that overall, buspirone did not appear to be helpful in alleviating benzodiazepine withdrawal symptoms. Buspirone (5 mg t.d.s.) or placebo was administered for four weeks before, during and after diazepam withdrawal. Patients taking buspirone had a markedly higher dropout rate (seven out of 11) than those taking placebo (one out of 12). Mean daily diazepam dosage at entry was significantly higher in the buspirone group, but overall initial diazepam dosage was not related to outcome. Higher subjectively rated anxiety at the start of withdrawal was significantly related to higher dropout rate, irrespective of treatment, and was greater (although not significantly so) in the buspirone group.

Type
Papers
Information
The British Journal of Psychiatry , Volume 157 , Issue 2 , August 1990 , pp. 232 - 238
Copyright
Copyright © Royal College of Psychiatrists, 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.Google Scholar
Ashton, H. (1984) Benzodiazepine withdrawal: an unfinished story. British Medical Journal, 288, 1135–1140.Google Scholar
Bond, A. J. & Lader, M. H. (1981) Comparative effects of diazepam and buspirone on subjective feelings, psychological tests and the EEC International Pharmacopsychiatry, 16, 212–220.Google Scholar
Chopin, P. & Briley, M. (1987) Animal models of anxiety: the effect of compounds that modify 5–HT transmission. Trends in Pharmacological Sciences, 8, 383–390.Google Scholar
Cohn, J. B., Bowden, C. L., Fisher, J. G., et al (1986) Double-blind comparison of buspirone and clorazepate in anxious out-patients. American Journal of Medicine, 80, 10–16.CrossRefGoogle Scholar
Dourish, J. R., Hutson, P. H. & Curzon, G. (1986) Putative anxiolytics 8–OH-DPAT, buspirone and TVXQ 7821 are agonists at 5–HT1A autoreceptors in the raphe nuclei. Trends in Pharmacological Sciences, 7, 212–214.Google Scholar
Eison, A. S. & Temple, D. L. (1986) Buspirone: review of its pharmacology and current perspectives in its mechanism of action. American Journal of Medicine, 80, 1–9.Google Scholar
Feighner, J. P., Merideth, C. H. & Hendrickson, G. A. (1982) A double-blind comparison of buspirone and diazepam in outpatients with generalised anxiety disorder. Journal of Clinical Psychiatry, 43, 103–107.Google Scholar
Fozard, J. R. (1987) 5HT: the enigma variations. Trends in Pharmacological Sciences, 8, 501–506.CrossRefGoogle Scholar
Lader, M. (1987) Long-term anxiolytic therapy: the issue of drug withdrawal. Journal of Clinical Psychiatry, 48, 12–16.Google Scholar
Lader, M. (1988) The practical use of buspirone. In Buspirone: A New Introduction to the Treatment of Anxiety (ed. M. Lader), pp 71–76. London: Royal Society of Medicine.Google Scholar
Montgomery, S. & Asberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.CrossRefGoogle Scholar
Murphy, S. M., Owen, R. & Tyrer, P. (1989) Comparative assessment of efficacy and withdrawal symptoms after six and twelve weeks treatment with diazepam or buspirone. British Journal of Psychiatry, 154, 529–534.CrossRefGoogle Scholar
Olajide, D. & Lader, M. (1987a) A comparative study of the efficacy of buspirone in relieving benzodiazepine withdrawal symptoms. Journal of Clinical Psychopharmacology, 7, 11–15.Google Scholar
Olajide, D. & Lader, M. (1987b) A comparison of buspirone, diazepam and placebo in patients with chronic anxiety states. Journal of Clinical Psychopharmacology, 7, 148–152.Google Scholar
Olajide, D. (1988) Buspirone as an alternative to the benzodiazepines: how effective? Abstracts of British Association for Psychopharmacology Summer Meeting, Jesus College, Cambridge, July 10–13. Journal of Psychopharmacology, 2.Google Scholar
Raskin, A., Schulterbrandt, J., Reatig, N., et al (1969) Replication of factors of psychopathology in interview, ward behaviour and self-report ratings of hospitalised depressives. Journal of Nervous Mental Disorders, 148, 87–89.Google Scholar
Rickels, K., Weisman, K., Norstad, N., et al (1982) Buspirone and diazepam in anxiety: a controlled study. Journal of Clinical Psychiatry, 43, 81–86.Google Scholar
Schweizer, E., Rickels, K. & Lucki, J. (1986) Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. New England Journal of Medicine, 314, 717–720.Google Scholar
Spitzer, R. L., Williams, J. B. W. & Gibbon, M. (1985) Instruction Manual for the Structured Clinical Interview for DSM–III–R (SCID, 7.1.85 revision). New York: Biometrics Research Department. New York State Psychiatric Institute.Google Scholar
Taylor, D. P., Hyslop, D. K. & Riblet, L. A. (1980) Buspirone: a new non-benzodiazepine anxiolytic. Transactions of the American Society of Neurochemistry, 11, 193.Google Scholar
The Lancet (1988) Buspirone – a radical advance in the treatment of anxiety? Lancet, i, 801–806.Google Scholar
Traber, J. & Glaser, T. (1987) 5-HT1A receptor-related anxiolytics. Trends in Pharmacological Sciences, 8, 432–437.Google Scholar
Tyrer, P. & Alexander, J. (1979) Classification of personality disorder. British Journal of Psychiatry, 135, 168–174.Google Scholar
Tyrer, P. & Owen, R. (1984) Anxiety in primary care: is short-term drug treatment appropriate? Journal of Psychiatric Research, 18, 73–78.Google Scholar
Tyrer, P., Owen, R. T. & Cicchetti, D. V. (1984) The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. Journal of Neurology, Neurosurgery, and Psychiatry, 47, 970–975.Google Scholar
Ziomond, A. S. & Snaith, R. P. (1983) The hospital anxiety and depression (HAD) scale. Acta Psychiatrica Scandinavica, 67, 361–370.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.